Advertisement

Loading...

Orpea SA

ORPEFPNK
Healthcare
Medical - Care Facilities
$14.22
$0.00(0.00%)
U.S. Market is Open • 11:20

Orpea SA Fundamental Analysis

Orpea SA (ORPEF) shows weak financial fundamentals with a PE ratio of -9.25, profit margin of -4.94%, and ROE of -12.96%. The company generates $4.3B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position16.41%
PEG Ratio-0.11

Areas of Concern

ROE-12.96%
Operating Margin8.44%
Current Ratio0.81
We analyze ORPEF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -14.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-14.1/100

We analyze ORPEF's fundamental strength across five key dimensions:

Efficiency Score

Weak

ORPEF struggles to generate sufficient returns from assets.

ROA > 10%
-1.63%

Valuation Score

Excellent

ORPEF trades at attractive valuation levels.

PE < 25
-9.25
PEG Ratio < 2
-0.11

Growth Score

Moderate

ORPEF shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Weak

ORPEF carries high financial risk with limited liquidity.

Debt/Equity < 1
4.84
Current Ratio > 1
0.81

Profitability Score

Weak

ORPEF struggles to sustain strong margins.

ROE > 15%
-1295.74%
Net Margin ≥ 15%
-4.94%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is ORPEF Expensive or Cheap?

P/E Ratio

ORPEF trades at -9.25 times earnings. This suggests potential undervaluation.

-9.25

PEG Ratio

When adjusting for growth, ORPEF's PEG of -0.11 indicates potential undervaluation.

-0.11

Price to Book

The market values Orpea SA at 1.25 times its book value. This may indicate undervaluation.

1.25

EV/EBITDA

Enterprise value stands at -8.54 times EBITDA. This is generally considered low.

-8.54

How Well Does ORPEF Make Money?

Net Profit Margin

For every $100 in sales, Orpea SA keeps $-4.94 as profit after all expenses.

-4.94%

Operating Margin

Core operations generate 8.44 in profit for every $100 in revenue, before interest and taxes.

8.44%

ROE

Management delivers $-12.96 in profit for every $100 of shareholder equity.

-12.96%

ROA

Orpea SA generates $-1.63 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.63%

Following the Money - Real Cash Generation

Operating Cash Flow

Orpea SA generates limited operating cash flow of $270.96M, signaling weaker underlying cash strength.

$270.96M

Free Cash Flow

Orpea SA produces free cash flow of $141.00M, offering steady but limited capital for shareholder returns and expansion.

$141.00M

FCF Per Share

Each share generates $0.87 in free cash annually.

$0.87

FCF Yield

ORPEF converts 7.10% of its market value into free cash.

7.10%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-9.25

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.11

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.25

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.46

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

4.84

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.81

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.13

vs 25 benchmark

ROA

Return on assets percentage

-0.02

vs 25 benchmark

ROCE

Return on capital employed

0.04

vs 25 benchmark

How ORPEF Stacks Against Its Sector Peers

MetricORPEF ValueSector AveragePerformance
P/E Ratio-9.2527.91 Better (Cheaper)
ROE-12.96%687.00% Weak
Net Margin-4.94%-45285.00% (disorted) Weak
Debt/Equity4.840.33 Weak (High Leverage)
Current Ratio0.812795.76 Weak Liquidity
ROA-1.63%-13557.00% (disorted) Weak

ORPEF outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Orpea SA's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ